摘要
目的比较丹红注射液与丹参川芎嗪注射液对急性冠状动脉综合征（acute coronary syndrome，ACS）导致的凝血因子Ⅶ水平异常的调节作用。方法将全部患者完全随机分为3组各60例，对照组采用西医常规治疗，丹红注射液组（A组）、丹参川芎嗪注射液组（B组）在对照组治疗基础上，分别给予丹红注射液和丹参川芎嗪注射液治疗，观察两药对ACS所致凝血因子Ⅶ水平异常的调节作用。结果B组对凝血因子Ⅶ水平异常的调节作用优于A组（X^2=3．67，P〈0．05），A、B两组对凝血因子Ⅶ的疗效均优于对照组（P〈0．05）。结论丹参川芎嗪注射液对凝血因子Ⅶ水平的调节作用优于丹红注射液；丹红注射液和丹参川芎嗪注射液对凝血因子Ⅶ水平有调节作用。
Objective To compare the regulatory functions of Danhong and Salvia Ligustrazin on abnormal coagulation factors VII caused by ACS. Methods All cases were randomly divided into group A and B and a control group. Each group contains 60 patients. The control group was treated with conventional western therapies. On this basis, group A was treated with Danhong injection and group B was treated with Salvia Ligustrazin injection. Compare the regulatory function of its group on abnormal level of coagulation factor Ⅶ caused by ACS. Results Group B showed better effects in its regulating abnormal level of coagulation factor VII as compared to group A （X^2= 3.67, P〈0.05） . Both groups did better than the control group in adjusting coagulation factors Ⅶ （P〈0.05） . Conclusion Salvia ligustrazine has better effect in regulating coagulation factors Ⅶ than Dan Hong injection, which is better than conventional western medical therapy.
出处
《国际中医中药杂志》
2010年第1期47-48,共2页
International Journal of Traditional Chinese Medicine
